Israel Chemicals Ltd (ICL) PT Raised to $6.50 at BMO Capital

BMO Capital analyst Joel Jackson raised the price target on Israel Chemicals Ltd (NYSE: ICL) to $6.50 (from $6.00) while maintaining a Market Perform rating.

The analyst commented: "Updating our model post last week's Q1 results and raising our target price to $6.50. We raise 2026E EBITDA ~$100M, now modeling in the upper half of ICL's raised EBITDA guidance ($1.5-1.7B); previously we modeled in the upper half of the prior $1.4-1.6B guide. Increases come mainly in potash (prices/margins) with a little from bromine/IP. Our $6.50 target price is still ~6x 2026E EV/EBITDA."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Critical One Energy closes second tranche of flow-through placement